Acute Toxicity and Histopathological Evaluation of Polyherbal Formulations of Annona Squamosa, Zingiber Officinalis and Triticum Aestivum in Wistar Rats
Abstract
The relationship between dose and its effects on the exposed organism is of high significance in toxic evaluation. The present study was aimed for the safety assessment of methanolic extract of Annona squamosa, Zingiber Officinalis and Triticum aestivum as polyherbal formulations at different ratios in albino Wistar rats. Sighting study was conducted in one female rat by administering 300 mg/kg body weight of polyherbal formulation through oral gavage. There were no clinical signs noticed in Sighting study Step I. Sighting study Step II was conducted in another female rat by administering 2000 mg/kg body weight. The animal did not reveal any clinical signs of toxicity and no mortality occurred in all polyherbal formulations for 24 h. Hence the main study was conducted in another set of four female rats by administering a dose of 2000 mg/kg body weight of test item through oral gavage as a single dose. All the animals were observed for 15 days and did not reveal any clinical signs of toxicity and mortality. There were no treatment-related changes observed in body weights and body weight gain up to 2000 mg/kg body weight, no external and internal gross pathological changes and no histopathological changes during the necropsy of animals were noticed. The results have revealed that all the three polyherbal formulations were well tolerated up to a maximum dose of 2000 mg/kg with no observed adverse effects and could be considered as nontoxic in acute ingestion. It also indicated that the LD50 lies at >2000 mg/kg body weight.
Keywords: Acute oral toxicity, polyherbal, Annona squamosa, Zingiber officinalis, Triticum aestivum
Cite this Article
R. Rajesh, S. D. Jagadeesh Singh, R. Channabasava. Acute Toxicity and Histopathological Evaluation of Polyherbal Formulations of Annona Squamosa, Zingiber Officinalis and Triticum Aestivum in Wistar Rats. Research & Reviews: A Journal of Drug Design & Discovery. 2019; 6(3): 1–7p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |